An Open-Label, Multicenter, Randomized, Phase II Study of Cisplatin and Pemetrexed With or Without Cixutumumab (IMC-A12) as a First-Line Therapy in Patients With Advanced Nonsquamous Non–Small Cell Lung Cancer
Novello, Silvia, Scagliotti, Giorgio, de Castro, Gilberto, Kiyik, Murat, Kowalyszyn, Rubén, Deppermann, Karl-Matthias, Arriola, Edurne, Bosquee, Lionel, Novosiadly, Ruslan D., Nguyen, Tuan S., Forest,Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2016.07.013
Date:
July, 2016
File:
PDF, 760 KB
english, 2016